Cargando…
Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
BACKGROUND: When treating bladder cancer patients, the most significant problems usually concern cases with high-grade non-muscle-invasive carcinoma, and a better understanding of which patients would benefit from early radical cystectomy is urgently needed. The uropathology community is seeking mor...
Autores principales: | Patriarca, Carlo, Hurle, Rodolfo, Moschini, Marco, Freschi, Massimo, Colombo, Piergiuseppe, Colecchia, Maurizio, Ferrari, Lucia, Guazzoni, Giorgio, Conti, Andrea, Conti, Giario, Lucianò, Roberta, Magnani, Tiziana, Colombo, Renzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721190/ https://www.ncbi.nlm.nih.gov/pubmed/26791567 http://dx.doi.org/10.1186/s13000-016-0466-6 |
Ejemplares similares
-
Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients
por: Valeri, Marina, et al.
Publicado: (2023) -
Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
por: Lim, So Dug, et al.
Publicado: (2015) -
Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
por: Maas, Moritz, et al.
Publicado: (2021) -
Invasion and metastasis: a historical perspective
por: Patriarca, Carlo, et al.
Publicado: (2020) -
Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study
por: Hurle, Rodolfo, et al.
Publicado: (2020)